Literature DB >> 11600128

Identification of genetic alterations in the TGFbeta type II receptor gene promoter.

E R Seijo1, H Song, M A Lynch, R Jennings, X Qong, E Lazaridis, C Muro-Cacho, C M Weghorst, T Muñoz-Antonia.   

Abstract

Modifications in the control sequences of tumor suppressor genes have been found to play a role in the activation or inactivation of these genes and may play an important role in tumorigenesis. For example, hypermethylation of CpG islands and promoter polymorphisms have been found to be involved in transcriptional repression. A decrease in the levels of expression of one such tumor suppressor gene, the TGFbeta type II receptor (TbetaR-II), has been associated with increased tumorigenicity in a number of human tumors. Genetic alterations have been described in several tumor types in the coding region of this gene. However, no comprehensive search for genetic alterations in the TbetaR-II promoter has been reported. Genetic alterations in the promoter of the TbetaR-II gene could inhibit binding of putative regulatory factors. For example, we have reported a A-364-G alteration in the TbetaR-II promoter, which results in decreased transcriptional activity. In this study, we analyzed the 1.0kb region upstream of the TbetaR-II transcriptional start site and found genetic alterations in 46% of the head and neck squamous cell carcinoma (SqCC) samples examined. The most frequent alteration was a G-875-A alteration, present in 41.6% of the samples. Analysis of normal healthy individuals showed a similar frequency of this alteration, suggesting that alterations within the TbetaR-II promoter are unlikely to account for the decreased expression of TbetaR-II in head and neck SqCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600128     DOI: 10.1016/s0027-5107(01)00217-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  14 in total

1.  Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yanli Guo; Gang Kuang; Zhibin Yang; Baoen Shan
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

Review 2.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

3.  Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.

Authors:  Wei Guo; Zhiming Dong; Yanli Guo; Zhifeng Chen; Zhibin Yang; Gang Kuang
Journal:  Mol Biol Rep       Date:  2011-07-22       Impact factor: 2.316

4.  Polymorphisms of VEGF, TGFβ1, TGFβR2 and conotruncal heart defects in a Chinese population.

Authors:  Enshi Wang; Zhenhua Wang; Shenghua Liu; Haiyong Gu; Dingxu Gong; Kun Hua; Yu Nie; Jue Wang; Haoran Wang; Jie Gong; YuJian Zhang; Hui Zhang; Ruiping Liu; Shengshou Hu; Hao Zhang
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

5.  A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.

Authors:  Mei Zhang; Ling-Ling Guo; Zhongqin Cheng; Reng-Yun Liu; Yufeng Lu; Qian Qian; Zhe Lei; Hong-Tao Zhang
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

6.  Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma.

Authors:  Teresita Muñoz-Antonia; Mariclara Torrellas-Ruiz; Jonathan Clavell; Linda A Mathews; Carlos A Muro-Cacho; Adriana Báez
Journal:  Int J Otolaryngol       Date:  2009-06-14

7.  Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.

Authors:  Melissa K Hypes; Lucia Pirisi; Kim E Creek
Journal:  Cancer Lett       Date:  2009-04-02       Impact factor: 8.679

8.  TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.

Authors:  Guangfu Jin; Yimei Deng; Ruifen Miao; Zhibin Hu; Yan Zhou; Yongfei Tan; Jianming Wang; Zhaolai Hua; Weiliang Ding; Lina Wang; Wensen Chen; Jing Shen; Xinru Wang; Yaochu Xu; Hongbing Shen
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-07       Impact factor: 4.553

9.  TGFβ-1 and TGFBR2 polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese nonsmoking females: a case control study.

Authors:  Yangwu Ren; Zhihua Yin; Kun Li; Yan Wan; Xuelian Li; Wei Wu; Peng Guan; Baosen Zhou
Journal:  BMC Med Genet       Date:  2015-04-10       Impact factor: 2.103

10.  Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer.

Authors:  Jose Diaz-Chavez; Rogelio Hernandez-Pando; Paul F Lambert; Patricio Gariglio
Journal:  Mol Cancer       Date:  2008-01-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.